EP Vantage is European Mediscience Commentator of the Year

EP Vantage is proud to have won the European Mediscience Commentator of the Year award for 2011. The award recognises the importance of clear and insightful commentary on the pharma and biotech sector and excellence in the way that knowledge is communicated to a wide audience.

Most Read

FDA guidance reinforces importance of companion diagnostics
Reflecting the growing significance of companion diagnostics in development of advanced health care, the FDA has proposed guidance that would tie the regulatory approval of “personalised” medicines to the tests that identify appropriate patients. ...

Tough IPO scene continues in first half 2011
While Endocyte shows what can be achieved through a successful IPO, the prospects for pharma and biotech companies going public in the US and Europe continue to be challenging. ...

Glaxo emerges as big spender as external pipeline grows
Alongside interim results GlaxoSmithKline boasted that it expects more than 30 read outs on 14 phase III assets by the end of next year. That is an awful of lot of data to emerge from what is now one of the industry’s largest drug pipelines, amassed by one of the most prolific deal makers. …